Alcohol
Volume 21, Issue 1 , Pages 11-17 , May 2000

Effects of ritanserin on ethanol withdrawal–induced anxiety in rats

Received 3 September 1999 ,Revised 25 October 1999 ,Accepted 25 October 1999.

References 

  1. Barnes NM, Cheng CH, Costall B, Ge J, Kelly ME, Naylor RJ. Profiles of interaction of R(+)/S(−)-zacopride and anxiolytic agents in a mouse model. Eur J Pharmacol. 1992;218:91–100
  2. Benjamin D, Lal H, Meyerson LR. The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze. Life Sci. 1990;47:195–203
  3. Benjamin D, Saiff EI, Nevins T, Lal H. Mianserin-induced 5HT2 receptor downregulation results in anxiolytic effects in the elevated plus maze. Drug Dev Res. 1992;26:287–297
  4. Bersani G, Pozzi F, Marini S, Grispini A, Pasini A, Ciani N, et al. 5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin. Acta Psychiatr Scand. 1991;83:244–248
  5. Chweh A, Swinyard E, Wolf H. Pentylenetetrazol may discriminate between different types of benzodiazepine receptors. J Neurochem. 1983;41:830–833
  6. Emmett-Oglesby MW, Spencer DG, Arnoult DE. A TSR-80-based system for the control of behavioral experiments. Pharmacol Biochem Behav. 1982;17:583–587
  7. Emmett-Oglesby MW, Harris CM, Lane JD, Lal H. Withdrawal from morphine generalizes to a pentylenetetrazol stimulus. Neuropeptides. 1984;5:37–40
  8. Emmett-Oglesby MW, Mathis DA, Harris CM, Idemudia SO, Lal H. Withdrawal from diazepam substitutes for the discriminative stimulus properties of pentylenetetrazol. J Pharmacol Exp Ther. 1988;244:892–897
  9. Emmett-Oglesby MW, Mathis D, Moon R, Lal H. Animal models of drug withdrawal symptoms. Psychopharmacology. 1990;101:292–309
  10. Fiorella D, Rabin RA, Winter JC. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine. Psychopharmacology. 1995;119:222–230
  11. Gatch MB, Wallis CJ, Lal H. The effects of adenosine ligands R-PIA and CPT on ethanol withdrawal. Alcohol. 1999;19:9–14
  12. Gommans J, Hijzen TH, Maes RA, Olivier B. Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action. Psychopharmacology. 1998;137:292–302
  13. Graeff FG, Guimares FS, De Andrade TG, Deakin JF. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav. 1996;54:129–141
  14. Graeff FG, Netto C, Zangrossi HJ. The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev. 1998;23:237–246
  15. Harris CM, Benjamin D, Lal H. Anxiety-like subjective effect of ethanol antagonist RO 15-4513 demonstrated in pentylenetetrazol discrimination. Neuropharmacology. 1987;26:1545–1547
  16. Idemudia SO, Bhadra S, Lal H. The pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal is potentiated by bicuculline and picrotoxinin. Neuropsychopharmacology. 1989;2:115–122
  17. Institute of Laboratory Animal Resources . Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press; 1996;
  18. Jung M, Wallis CJ, Gatch M, Lal H. Sex differences in the pentylenetetrazol-like stimulus induced by ethanol withdrawal. J Pharmacol Exp Ther. 1999;291:516–582
  19. Lal H, Emmett-Oglesby MW. Behavioral analogues of anxiety. Animal models. Neuropharmacology. 1983;22:1423–1441
  20. Lal H, Harris CM, Benjamin D, Springfield AC, Bhadra S, Emmett-Oglesby MW. Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal. J Pharmacol Exp Ther. 1988;247:508–518
  21. Lal H, Prather PL, Rezazadeh SM. Anxiogenic behavior in rats during acute and protracted ethanol withdrawal: reversal by buspirone. Alcohol. 1991;8:467–471
  22. Lal H, Prather PL, Rezazadeh SM. Potential role of 5HT1C and/or 5HT2 receptors in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal. Alcohol Clin Exp Res. 1993;17:411–417
  23. Lal H, Shearman GT, Fielding S, Dunn R, Kruse H, Theurer K. Evidence that GABA mechanisms mediate the anxiolytic action of benzodiazepines: a study with valproic acid. Neuropharmacology. 1980;19:785–789
  24. Leysen J, Gommeren W, Van Gompel P, Wynants J, Janssen P, Laduron P. Receptor-binding properties in vitro and in vivo of ritanserin: a very potent and long acting serotonin-S2 antagonist. Mol Pharmacol. 1985;27:600–611
  25. Mora PO, Netto CF, Graeff FG. Role of 5-HT2A and 5-HT2C receptor subtypes in the two types of fear generated by the elevated T-maze. Pharmacol Biochem Behav. 1997;58:1051–1057
  26. Moy S, Knapp D, Criswell H, Breese G. Flumazenil blockade of anxiety following ethanol withdrawal in rats. Psychopharmacology. 1997;131:354–360
  27. Pandey S, Piano M, Schwertz D, Davis J, Pandey G. Effect of ethanol administration and withdrawal on serotonin receptor subtypes and receptor-mediated phosphoinositide hydrolysis in rat brain. Alcohol Clin Exp Res. 1992;16:1110–1116
  28. Prather PL, Rezazadeh SM, Lal H. Mianserin in the treatment of ethanol withdrawal in the rat: prevention of behaviors indicative of anxiety. Psychopharmacol Bull. 1991;27:285–289
  29. Ramanjaneyulu R, Ticku M. Interaction of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine–GABA receptor–ionophore complex. Eur J Pharmacol. 1984;98:337–345
  30. Rezazadeh SM, Prather PL, Lal H. Sensitization to 5-HT1C receptor agonist in rats observed following withdrawal from chronic ethanol. Alcohol. 1993;10:281–283
  31. Rodin E, Calhoun H. Metrazol tolerance in a “normal” volunteer population. J Psychiatr Res. 1970;13:65–76
  32. Shader R, Greenblatt D. The pharmacotherapy of acute anxiety. In:  Bloomand F,  Kupfer D editor. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995;p. 1341–1348
  33. Shearman GT, Lal H. Generalization and antagonism studies with convulsant, GABAergic and anticonvulsant drugs in rats trained to discriminate pentylenetetrazol from saline. Neuropharmacology. 1980;19:473–479
  34. Stutzmann J, Eon B, Darche F, Lucas M, Rataud J, Piot O, et al. Are 5-HT2 antagonists endowed with anxiolytic properties in rodents?. Neurosci Lett. 1991;128:4–8
  35. Wallis CJ, Lal H. A discriminative stimulus produced by 1-(3-chlorophenyl)-piperazine (MCPP) as a putative animal model of anxiety. Prog Neuropsychopharmacol Biol Psychiatry. 1998;22:547–565
  36. Wallis CJ, Rezazaden S, Lal H. Role of serotonin in ethanol abuse. Drug Dev Res. 1993;30:178–188
  37. Wallis CJ, Rezazadeh SM, Lal H. GM1 ganglioside reduces ethanol intoxication and the development of ethanol dependence. Alcohol. 1995;12:573–580
  38. Wood DM, Lal H. Anxiogenic properties of cocaine withdrawal. Life Sci. 1987;41:1431–1436
  39. Wright IK, Heaton M, Upton N, Marsden CA. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze. Psychopharmacology. 1992;107:405–414

PII: S0741-8329(99)00095-6

Alcohol
Volume 21, Issue 1 , Pages 11-17 , May 2000

Article Tools

* Image Usage & Resolution